Cannabinoid receptor 2 selective agonist alleviates systemic sclerosis by inhibiting Th2 differentiation through JAK/SOCS3 signaling
Na Tian, Hao Cheng, Yu Du, Xiaoxia Wang, Lei Yi, Xinnan Liu, Miao Chen, Zhan Xu, Lingbiao Wang, Hanlin Yin, Rong Fu, Dan Li, Penghui Zhou, Liangjing Lu, Zhinan Yin, Sheng‐Ming Dai, Bin Li, Sheng‐Ming Dai, Bin Li
Topics & Concepts
AgonistCannabinoid receptorCannabinoid receptor type 2CannabinoidChemistryPharmacologySOCS3ReceptorEndocannabinoid systemSignal transductionMedicineBiochemistrySTAT3Systemic Sclerosis and Related DiseasesMast cells and histamineHops Chemistry and Applications